摘要
The Author Reply: We thank Pitcairn et al. [1] for their discussion of our study recently published in Hepatobiliary & Pancreatic Diseases International [2]. They highlighted the added value that contrast-enhanced ultrasonography(CEUS) can present in low-resource settings, where other diagnostic modalities may be neither cost-effective nor readily available. We agree with their point. In addition, we also would like to highlight that CEUS is safer for human body than computed tomography(CT) and magnetic resonance imaging(MRI).
